市場調查報告書
商品編碼
1276567
皮膚消毒劑全球市場規模、份額和行業趨勢分析報告:按類型、分銷渠道、形式、地區、前景和預測,2023-2029 年Global Skin Antiseptic Market Size, Share & Industry Trends Analysis Report By Type (Alcohol, Chlorhexidine, Iodine), By Distribution Channel, By Form (Solutions, Swab Sticks, Cream), By Regional Outlook and Forecast, 2023 - 2029 |
到 2029 年,皮膚消毒劑市場規模預計將達到 25 億美元,預測期內復合年增長率為 7.4%。
院內感染髮生率的增加是推動皮膚消毒劑需求的主要因素。 醫療保健中心的患者可能會感染導致這些疾病的細菌、病毒和其他病菌。 HAI 可引起範圍廣泛的疾病,從輕微到嚴重,有時甚至是致命的。 因此,醫療機構必須遵守嚴格的衛生標準,包括皮膚消毒劑,以預防 HAI。 此外,皮膚消毒劑對於降低侵入性操作(例如手術和其他醫療操作)後的感染風險很重要。
此外,已經證實,由於醫療費用飆升,全球防腐劑市場的增長率正在上升。 醫療保健部門的擴張更加強調提高護理標準和降低感染率。 因此,對防腐劑,尤其是皮膚防腐劑的需求不斷增加。
COVID-19 影響分析
皮膚消毒劑現在在醫療機構之外使用,這對市場擴張產生了積極影響。 酒精含量較高的洗手液是用於皮膚消毒的皮膚消毒劑的主流。 它可以去除大多數細菌和病毒,而不僅僅是 COVID-19 病毒。 除了洗手液,還使用酒精濕巾、噴霧等皮膚消毒劑。 因此,大流行對市場擴張做出了積極貢獻。
市場增長因素
交通事故增加
行人、騎自行車的人和騎摩托車的人佔所有交通死亡人數的一半以上。 儘管擁有世界上約 60% 的汽車保有量,但中低收入國家仍佔交通死亡人數的 93%。 隨著道路交通傷害人數的增加,醫療保健專業人員面臨著提供有效和及時護理的壓力。 隨著交通事故的增加,用於治療傷口的皮膚消毒劑的需求也在增加。
HAI 發病率增加
不斷增長的老年人口和糖尿病、心贓病、癌症、肥胖症和呼吸系統疾病等慢性病病例的增加是 HAI 增加的主要原因。 多年來,全世界進行的外科手術數量顯著增加。 外科手術比例的增加增加了對各種手術器械和醫療器械的需求。 預計這會增加院內感染的發生率。 預計皮膚消毒劑市場將會增長,以避免對 HAI 的市場開發。
市場抑制因素
皮膚消毒劑的殺菌問題
固有污染髮生在製造過程中。 由於許多皮膚消毒劑都是水性的,這個問題影響所有水性製造商,除非產品經過滅菌或包裝後滅菌。 因為很難也不可能從水系統中去除含有微生物的生物膜,所以這些微生物中的一些無疑會在製造過程中感染最終產品。 作為對策, "絕育" 很常見。 未來,皮膚消毒劑的問題可能會阻礙市場擴張。
輸入 Outlook
按類型劃分,皮膚消毒劑市場分為酒精、洗必太、碘和其他。 在 2022 年的皮膚消毒劑市場中,氯己定細分市場贏得了可觀的收入份額。 皮膚感染用洗必泰(一種局部消毒劑)治療。 它的作用是去除皮膚上的真菌和細菌。 因此,諸如疔瘡、痤瘡和濕疹之類的皮膚病經常使用此類藥物進行治療。 此外,這種物質用於消毒和清潔皮膚。 它還有助於防止皮膚刺激。
銷售渠道前景
按分銷渠道,皮膚消毒劑市場分為醫院藥房、在線供應商以及藥店和零售藥店。 2022 年,藥店和零售藥房細分市場主導了皮膚消毒劑市場,佔據了最大的收入份額。 這主要是由於對門診護理的需求增加以及對感染控制的影響的理解不斷加深。 此外,皮膚消毒劑在這些商店的易得性也是支持該細分市場擴張的因素之一。
形態觀
皮膚消毒劑市場按形式分為溶液、乳膏、藥籤等。 到 2022 年,面霜部分將在皮膚消毒劑市場中佔據重要的收入份額。 輕微燒傷、燒傷、割傷和擦傷、龜裂、曬傷、乾燥、尿布疹、蚊蟲叮咬、老年斑和丘疹可以用抗菌霜治療,這些霜可以舒緩和治癒傷口,同時防止感染。 因此,面霜的易得性是促進生長的關鍵因素。
區域展望
按地區劃分,我們對四個地區的皮膚消毒劑市場進行了分析:北美、歐洲、亞太地區和拉丁美洲/中東/非洲。 到 2022 年,亞太地區將在皮膚消毒劑市場佔據重要的收入份額。 主要的市場驅動力之一是增加公共和私營部門的醫療保健支出。 由於這種情況,市場預計會增加,並有望吸引幾家大型本地企業。
The Global Skin Antiseptic Market size is expected to reach $2.5 billion by 2029, rising at a market growth of 7.4% CAGR during the forecast period.
Skin antiseptics are compounds applied to the skin surface to eradicate or prevent the growth of germs. These substances are applied to the skin before surgical procedures to prevent infections. Skin antiseptics are crucial for maintaining a sterile environment when performing surgery or other invasive medical operations. The main goal of employing skin antiseptics is to lessen the number of bacteria on the skin's surface since these organisms might cause infections if they enter the body through a cut or other surgical invasion.
The danger of infections and the consequences they cause can be drastically decreased by healthcare professionals utilizing skin antiseptics. Also, there are numerous kinds of skin antiseptics available, including liquids, sprays, gels, and wipes. A wide variety of bacteria can be defeated by the active chemicals they contain. Povidone-iodine, chlorhexidine, and alcohol are the most often utilized active components in skin antiseptics.
The increased incidence of hospital-acquired infections is the primary factor driving the demand for skin antiseptics. Patients in a healthcare center can pick up bacteria, viruses, and other germs that cause these ailments. HAIs can result in various illnesses, from minor to serious, and can occasionally even result in death. Therefore, healthcare institutions must uphold strict hygiene standards, including skin antiseptics, to prevent HAIs. Skin antiseptics are furthermore crucial for lowering the risk of infection after intrusive treatments like surgeries and other medical procedures.
Moreover, a faster rate of growth in the antiseptic market has been observed globally due to rising healthcare costs. A greater emphasis is being placed on raising the standard of treatment and lowering infection rates as a result of the expanding healthcare sector. As a result, there is a rise in the demand for antiseptics, notably skin antiseptics.
COVID-19 Impact Analysis
The use of skin antiseptics extended outside of medical facilities, which had a favorable effect on the market expansion. The most popular skin antiseptics for skin disinfection are hand sanitizers having a significant proportion of alcohol content. They are capable of eliminating the COVID-19 virus as well as the majority of bacteria and viruses. Other skin antiseptics, like wipes and sprays with alcohol as an ingredient, are utilized in addition to hand sanitizers. Consequently, the pandemic contributed positively to market expansion.
Market Growth Factors
Rise in occurrence of road accidents
Pedestrians, bicyclists, and motorcyclists make up more than half of all road traffic fatalities. Despite the fact that low- and middle-income nations have about 60% of the world's vehicles, they account for 93% of all traffic deaths. Given the rise in traffic-related injuries, healthcare practitioners are under a lot of pressure to deliver effective and timely care. The need for skin antiseptics for wound care and other uses will increase along with traffic accidents.
Growing occurrence of HAI
The increase in the geriatric population, and the growth in cases of chronic conditions like diabetes, heart, cancer, obesity, and respiratory ailments are the leading causes of the rise in HAI. Over the years, the number of surgical operations carried out globally has risen significantly. The growing percentage of surgical operations has increased the demand for various surgical apparatus and medical devices. This is anticipated to increase the rate of hospital-acquired infections. In order to avoid the development of HAI, the market for cutaneous antiseptics is anticipated to expand.
Market Restraining Factors
Concerns regarding the sterilization of skin antiseptics
Intrinsic contamination happens throughout the manufacturing process. Since most skin antiseptics are water-based, this problem will affect all water-based manufacturers unless the product can be sterilized or is sterilized after packaging. Due to the difficulty or impossibility of removing biofilms containing microorganisms from water systems, some of these organisms will undoubtedly infect the finished product during production. The main remedy for this would seem straightforward: sterilize the finished item. Over the projected time, the problem with skin antiseptics may impede market expansion.
Type Outlook
Based on type, the skin antiseptic market is segmented into alcohol, chlorhexidine, iodine and others. The chlorhexidine segment acquired a significant revenue share in the skin antiseptic market in 2022. Skin infections are treated with chlorhexidine, a topical antiseptic. It operates by eliminating skin-based fungi and germs. Therefore, skin problems like boils, acne, and eczema are frequently treated with this kind of treatment. Moreover, this substance is utilized to sanitize and clean the skin. Also, it helps to avoid skin inflammation.
Distribution Channel Outlook
By distribution channel, the skin antiseptic market is bifurcated into hospital pharmacies, online providers, drug stores & retail pharmacies. In 2022, the drug stores & retail pharmacies segment dominated the skin antiseptic market with the maximum revenue share. It is primarily driven by the rising demand for outpatient treatments and the growing understanding of the significance of infection control. Additionally, the easy accessibility of skin antiseptics from these stores is one of the factors supporting market expansion in this segment.
Form Outlook
On the basis of form, the skin antiseptic market is fragmented into solutions, cream, swab sticks, and others. The cream segment covered a considerable revenue share in the skin antiseptic market in 2022. Minor burns and scalds, cuts & grazes, chapped skin, tiny areas of sunburn, dryness, diaper rash, bug bites, spots, and pimples can all be treated with antiseptic cream also soothes and cures wounds while preventing infection. The key component promoting the growth is the creams' simple availability.
Regional Outlook
Region wise, the skin antiseptic market is analyzed across North America, Europe, Asia Pacific and LAMEA. The Asia Pacific region garnered a significant revenue share in the skin antiseptic market in 2022. One of the main market drivers is the rise in healthcare spending in both the public and private sectors. The market is likely to increase as a result of this scenario, which is expected to attract several major and local businesses.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include XTTRIUM Laboratories, Sirmaxo Chemicals Private Limited, SCHULKE & Mayr GmbH, MOLNLYCKE Health Care (Investor AB), Cardinal Health, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, 3M Company, PDI Healthcare, Inc. and Ecolab, Inc.
Strategies deployed in Skin Antiseptic Market
Apr-2023: 3M Health Care launched the new FDA-approved 3M SoluPrep S Sterile Antiseptic Solution chlorhexidine gluconate (2% w/v) and isopropyl alcohol (70% v/v) Patient Preoperative Skin Preparation. The product has been shown to have fast-acting, broad-spectrum antibacterial action (in vitro; clinical significance unknown) and to persist in healthy human volunteers for at least 96 hours post-prep. 3M SoluPrep S Sterile Antiseptic Solution offers the efficacy healthcare professionals can rely on with the same active ingredients as the industry leader and additional benefits to help patients be protected. It is ideal for operating room nurses, doctors, and infection control professionals who want to prepare patient skin safely, effectively, and confidently before surgery to get rid of microorganisms on the skin that could potentially cause skin infections.
Jul-2022: Schulke Group took over Wet Wipes A/S, a market leader in surface wipes in the Scandinavian healthcare market. The acquisition complemented the company's product portfolio and would help in further expansion to the Scandinavian market.
Mar-2022: PDI Healthcare announced the dual launch of Sani-24® Germicidal Disposable Wipe, Sani-HyPerCide® Germicidal Spray, and Sani-HyPerCide® Germicidal Disposable Wipe, the novel, and innovative disinfectants. These products would help professionals in infection prevention in the fight against COVID-19 and healthcare-associated infections.
Mar-2022: Cardinal Health introduced the first surgical incise drape utilizing industry-leading antiseptic Chlorhexidine Gluconate (CHG). The drape has patented BeneHold CHG adhesive technology from Avery Dennison, which helps lower the risk of surgical site contamination with microorganisms that are frequently linked to surgical site infections (SSIs). The incise film offers a sterile surface to create a barrier to contamination and is sturdy, conformable, and breathable. Using CHG's antimicrobial characteristics in the surgical drape's adhesive is a novel strategy that aims to improve patient care by further lowering the risk of microbial contamination. CHG is a trusted topical antiseptic for surgical patient skin preparation.
Jan-2022: B. Braun opened a state-of-art Haemodialysis Concentrate Factory in the Thanh Oai Industrial Complex in Hanoi, Vietnam. With an initial investment of USD 5 million and a construction footprint of roughly 4000m2, the Haemodialysis Concentrate Factory enabled B. Braun Vietnam to supply the domestic and international markets with more than 2.5 million 10-litre canisters of hemodialysis each year. Additionally, it will make it possible for B. Braun Vietnam to continue serving the market and contribute to the daily protection and enhancement of the health of thousands of patients in Vietnam and all over the world.
Jun-2021: Schulke & Mayr GmbH announced an exclusive distribution agreement with Bactiguard for its wound care solutions' range to German hospitals. The agreement enabled Schulke to add Bactiguard's hypochlorous acid-based portfolio to its extensive line of antibacterial and wound care products.
Jul-2020: BD introduced the BD PurPrep patient preoperative skin preparation with a sterile solution. This solution is the first and single fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation commercially accessible in the United States.
Market Segments covered in the Report:
By Type
By Distribution Channel
By Form
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures